![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Sponsors and Collaborators: |
Shalvata Mental Health Center Brainsway |
---|---|
Information provided by: | Shalvata Mental Health Center |
ClinicalTrials.gov Identifier: | NCT00807105 |
This is a prospective open label study of acute and maintenance treatment of MDD. The acute phase consists of daily treatments for 4 weeks. maintenance will be twice a week for eight weeks followed by 10 weeks of once a week treatments.
Condition | Intervention | Phase |
---|---|---|
Major Depressive Disorder |
Device: H-COIL tms Device: h-COIL tms Device: h-COIL TMS |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Estimated Enrollment: | 12 |
Study Start Date: | June 2008 |
Estimated Study Completion Date: | June 2009 |
Estimated Primary Completion Date: | June 2009 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Eiran Harel | 097478644 | evharel@clalit.org.il |
Israel | |
ShalvataMHC | Recruiting |
Hod Hasharon, Israel | |
Contact: Eiran 097478644 evharel@clalit.org.il | |
SHALVATAMHC | Recruiting |
HOD HASHARON, Israel | |
Contact: EIRAN 097478644 EVHAREL@CLALIT.ORG.IL |
Responsible Party: | shalvataMHC ( E Harel ) |
Study ID Numbers: | 0013-07 SHA |
Study First Received: | November 20, 2008 |
Last Updated: | March 18, 2009 |
ClinicalTrials.gov Identifier: | NCT00807105 History of Changes |
Health Authority: | Israel: Ministry of Health |
MOOD EVALUATION |
Depression Mental Disorders Mood Disorders |
Depressive Disorder, Major Depressive Disorder Behavioral Symptoms |
Depression Mental Disorders Mood Disorders |
Depressive Disorder, Major Depressive Disorder Behavioral Symptoms |